Iloprost treatment in patients with Raynauds Phenomenon secondary to systemic sclerosis Iloprost treatment in patients with Raynaud’s phenomenon secondary to systemic sclerosis and the quality of life: a new therapeutic protocol ( Milio et al, 2006)
